Details

Autor(en) / Beteiligte

• Rosenzweig, Sergio
• Abel, Laurent
• Adimi, Parisa
• Al-Ghonaium, Abdulaziz
• de la Calle Martin, Oscar
• Feinberg, Jacqueline
• Yang, Kun
• Khalilzadeh, Soheila
• Chuzhanova, Nadia
• de Beaucoudrey, Ludovic
• Bustamante, Jacinta
• Al-Mohsen, Ibrahim
• Holland, Steven M
• Cooper, David N
• Furthner, Dieter
• Alcais, Alexandre
• Filipe-Santos, Orchidée
• Boisson-Dupuis, Stéphanie
• Mansouri, Davood
• Vogt, Guillaume
• Engelhorn, Carolin
• Al-Hajjar, Sami
• Mirsaeidi, Mehdi
• Casanova, Jean-Laurent
• Bauer, Thomas R
• Soudais, Claire
• Ochs, Hans D
• Chapgier, Ariane
• Fieschi, Claire
• Belohradsky, Bernd
• Puck, Jennifer M
• Schreiber, Robert D

Titel

Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations

Ist Teil von

• Nature genetics, 2005-07, Vol.37 (7), p.692-700

Ort / Verlag

London: Nature Publishing Group

Erscheinungsjahr

2005

Quelle

MEDLINE

Beschreibungen/Notizen

• Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N-glycosylation site in the IFNgammaR2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFNgamma. We then searched the Human Gene Mutation Database for potential gain-of-N-glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations ( approximately 1.4%) in 77 genes ( approximately 13.3%). Six mutant proteins bore new N-linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N-glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N-linked carbohydrate.